Chapter I. General Introduction
I- 4. Objectives of this study
3. Investigation of the Bacillus cereus-targeting bacteriophage genomes for further application
I-5. References
1. Andreatti Filho RL, Higgins JP, Higgins SE, Gaona G, Wolfenden AD, Tellez G, Hargis BM. 2007. Ability of bacteriophages isolated from different sources to reduce Salmonella enterica serovar Enteritidis in vitro and in vivo. Poult. Sci. 86:1904-1909.
2. Anonymous. 2006. The community summary report on trends and sources of zoonoses, zoonotic agents, antimicrobial resistance and foodborne outbreaks in the European Union in 2005. EFSA J. 94:2-228.
3. Athamna A, Athamna M, Abu-Rashed N, Medlej B, Bast DJ,
Rubinstein E. 2004. Selection of Bacillus anthracis isolates resistant to antibiotics. J. Antimicrob. Chemoth. 54:424-428.
4. Atterbury RJ, Van Bergen MAP, Ortiz F, Lovell MA, Harris JA, De Boer A, Wagenaar JA, Allen VM, Barrow PA. 2007. Bacteriophage therapy to reduce Salmonella colonization of broiler chickens. Appl.
Environ. Microbiol. 73:4543-4549.
5. Bandara N, Jo J, Ryu S, Kim K-P. 2012. Bacteriophages BCP1-1 and BCP8-2 require divalent cations for efficient control of Bacillus cereus in fermented foods. Food Microbiol. 31:9-16.
6. Barbara G, Stanghellini V, Berti-Ceroni C, De Giorgio R, Salvioli B, Corradi F, Cremon C, Corinaldesi R. 2000. Role of antibiotic therapy on long-term germ excretion in faeces and digestive symptoms after Salmonella infection. Aliment. Pharmacol. Ther. 14:1127-1131.
7. Barrangou R, Fremaux C, Deveau H, Richards M, Boyaval P, Moineau S, Romero DA, Horvath P. 2007. CRISPR provides acquired resistance against viruses in prokaryotes. Science 315:1709-1712.
8. Bartlett JG, Inglesby TV, Jr., Borio L. 2002. Management of anthrax.
Clin. Infect. Dis. 35:851-858.
9. Bottone EJ. 2010. Bacillus cereus, a volatile human pathogen. Clin.
Microbiol. Rev. 23:382-398.
10. Brenner F, Villar R, Angulo F, Tauxe R, Swaminathan B. 2000.
Salmonella nomenclature. J. Clin. Microbiol. 38:2465-2467.
11. Bruttin A, Brussow H. 2005. Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy. Antimicrob. Agents Chemother. 49:2874-2878.
12. Bruynoghe R, Maisin J. 1921. Essais de therapeutique au moyen du bacteriophage. CR Soc. Biol. 85:1120-1121.
13. Cairns BJ, Payne RJH. 2008. Bacteriophage therapy and the mutant selection window. Antimicrob. Agents Chemother. 52:4344-4350.
14. Calendar R, Abedon ST. 2005. The bacteriophages. Oxford University Press.
15. Capparelli R, Nocerino N, Lanzetta R, Silipo A, Amoresano A, Giangrande C, Becker K, Blaiotta G, Evidente A, Cimmino A. 2010.
Bacteriophage-resistant Staphylococcus aureus mutant confers broad immunity against staphylococcal infection in mice. PLoS ONE 5:e11720.
16. Carey-Smith GV, Billington C, Cornelius AJ, Hudson JA, Heinemann JA. 2006. Isolation and characterization of bacteriophages infecting Salmonella spp. FEMS Microbiol. Lett. 258:182-186.
17. Casjens SR, Gilcrease EB, Winn-Stapley DA, Schicklmaier P,
Schmieger H, Pedulla ML, Ford ME, Houtz JM, Hatfull GF, Hendrix RW. 2005. The generalized transducing Salmonella bacteriophage ES18:
complete genome sequence and DNA packaging strategy. J. Bacteriol.
187:1091-1104.
18. CDC. 2007. Bacterial foodborne and diarrheal disease national sase surveillance. Annual Report, 2005. Centers for Disease Control and Prevention, Atlanta.
19. Ceuppens S, Rajkovic A, Heyndrickx M, Tsilia V, Van De Wiele T, Boon N, Uyttendaele M. 2011. Regulation of toxin production by Bacillus cereus and its food safety implications. Crit. Rev. Microbiol.
37:188-213.
20. Chan RK, Botstein D, Watanabe T, Ogata Y. 1972. Specialized transduction of tetracycline resistance by phage P22 in Salmonella typhimurium : II. Properties of a high-frequency-transducing lysate.
Virology 50:883-898.
21. Choo E, Jang SS, Kim K, Lee KG, Heu S, Ryu S. 2007. Prevalence and genetic diversity of Bacillus cereus in dried red pepper in Korea. J. Food Prot. 70:917-922.
22. Coffey B, Mills S, Coffey A, McAuliffe O, Ross RP. 2010. Phage and their lysins as biocontrol agents for food safety applications. Annu. Rev.
Food Sci. Technol. 1:449-468.
23. d'Hérelle F. 1921. Le bactériophage; son rôle dans l'immunité. Masson et cie.
24. d'Hérelle F, Smith GH. 1926. The bacteriophage and its behavior. Am Assoc Immnol.
25. d’Herelle F. 1917. An invisible microbe that is antagonistic to the dysentery bacillus.
26. Daffonchio D, Cherif A, Borin S. 2000. Homoduplex and heteroduplex polymorphisms of the amplified ribosomal 16S-23S internal transcribed spacers describe genetic relationships in the "Bacillus cereus group". Appl.
Environ. Microbiol. 66:5460-5468.
27. Duckworth DH. 1976. "Who discovered bacteriophage?". Bacteriological Rev. 40:793-802.
28. El-Arabi T, Griffiths M, She Y-M, Villegas A, Lingohr E, Kropinski A.
2013. Genome sequence and analysis of a broad-host range lytic bacteriophage that infects the Bacillus cereus group. Virol. J. 10:48.
29. Fineran PC, Blower TR, Foulds IJ, Humphreys DP, Lilley KS, Salmond GP. 2009. The phage abortive infection system, ToxIN, functions as a protein–RNA toxin–antitoxin pair. Proc. Nat. Acad. Sci.
USA 106:894-899.
30. Fluit AC. 2005. Towards more virulent and antibiotic-resistant Salmonella? FEMS Immunol. Med. Microbiol. 43:1-11.
31. Granum PE, Lund T. 1997. Bacillus cereus and its food poisoning toxins.
FEMS Microbiol. Lett. 157:223-228.
32. Greenfield RA, Bronze MS. 2003. Prevention and treatment of bacterial diseases caused by bacterial bioterrorism threat agents. Drug Discovery Today 8:881-888.
33. Greer GG. 2005. Bacteriophage control of foodborne bacteria. J. Food Protect.\ 68:1102-1111.
34. Helgason E, Okstad OA, Caugant DA, Johansen HA, Fouet A, Mock M, Hegna I, Kolsto AB. 2000. Bacillus anthracis, Bacillus cereus, and Bacillus thuringiensis--one species on the basis of genetic evidence. Appl.
Environ. Microbiol. 66:2627-2630.
35. Higgins JP, Andreatti Filho RL, Higgins SE, Wolfenden AD, Tellez G, Hargis BM. 2008. Evaluation of Salmonella-Lytic properties of
bacteriophages isolated from commercial broiler houses. Avian Dis.
52:139-142.
36. Ho TD, Slauch JM. 2001. OmpC is the receptor for Gifsy-1 and Gifsy-2 bacteriophages of Salmonella. J. Bacteriol. 183:1495-1498.
37. Hong J, Kim K-P, Heu S, Lee SJ, Adhya S, Ryu S. 2008. Identification
of host receptor and receptor-binding module of a newly sequenced T5-like phage EPS7. FEMS Microbiol. Lett. 289:202-209.
38. Hudson JA, Billington C, Carey-Smith G, Greening G. 2005.
Bacteriophages as biocontrol agents in food. J. Food Protect. 68:426-437.
39. Jensen GB, Hansen BM, Eilenberg J, Mahillon J. 2003. The hidden lifestyles of Bacillus cereus and relatives. Environ. Microbiol. 5:631-640.
40. Kagawa H, Ono N, Enomoto M, Komeda Y. 1984. Bacteriophage chi sensitivity and motility of Escherichia coli K-12 and Salmonella typhimurium Fla- mutants possessing the hook structure. J. Bacteriol.
157:649-654.
41. Karginov FV, Hannon GJ. 2010. The CRISPR system: small RNA-guided defense in bacteria and archaea. Mol. Cell 37:7-19.
42. Kim M, Ryu S. 2011. Characterization of a T5-like coliphage SPC35 and differential development of resistance to SPC35 in Salmonella
Typhimurium and Escherichia coli. Appl. Environ. Microbiol. 77:2042-2050.
43. Kim SK, Kim KP, Jang SS, Shin EM, Kim MJ, Oh S, Ryu S. 2009.
Prevalence and toxigenic profiles of Bacillus cereus isolated from dried red peppers, rice, and Sunsik in Korea. J. Food Prot. 72:578-582.
44. King AM, Adams MJ, Lefkowitz E. 2011. Virus taxonomy: ninth report of the International Committee on Taxonomy of Viruses. Elsevier.
45. Kiyomizu K, Yagi T, Yoshida H, Minami R, Tanimura A, Karasuno T, Hiraoka A. 2008. Fulminant septicemia of Bacillus cereus resistant to carbapenem in a patient with biphenotypic acute leukemia. J. Infect.
Chemother. 14:361-367.
46. Kong M, Kim M, Ryu S. 2012. Complete genome sequence of Bacillus cereus bacteriophage PBC1. J. Virol. 86:6379-6380.
47. Kotiranta A, Lounatmaa K, Haapasalo M. 2000. Epidemiology and pathogenesis of Bacillus cereus infections. Microb. Infect. 2:189-198.
48. Kutter E, Sulakvelidze A. 2004. Bacteriophages: biology and applications. CRC Press.
49. Labrie SJ, Samson JE, Moineau S. 2010. Bacteriophage resistance mechanisms. Nature Rev. Microbiol. 8:317-327.
50. Lee WJ, Billington C, Hudson JA, Heinemann JA. 2011. Isolation and characterization of phages infecting Bacillus cereus. Lett. Appl. Microbiol.
52:456-464.
51. Logan NA. 2012. Bacillus and relatives in foodborne illness. J. Appl.
Microbiol. 112:417-429.
52. Mahichi F, Synnott AJ, Yamamichi K, Osada T, Tanji Y. 2009. Site-specific recombination of T2 phage using IP008 long tail fiber genes provides a targeted method for expanding host range while retaining lytic activity. FEMS Microbiol. Lett. 295:211-217.
53. Mc Grath S, Van Sinderen D. 2007. Bacteriophage: genetics and molecular biology. Caister Academic Press.
54. McLaughlin MR, Balaa MF, Sims J, King R. 2006. Isolation of
Salmonella bacteriophages from swine effluent lagoons. J. Environ. Qual.
35:522-528.
55. McLaughlin MR, King RA. 2008. Characterization of Salmonella bacteriophages isolated from swine lagoon effluent. Curr. Microbiol.
56:208-213.
56. Mead PS, Slutsker L, Dietz V, McCaig LF, Bresee JS, Shapiro C, Griffin PM, Tauxe RV. 1999. Food-related illness and death in the United States. Centers for Disease Control.
57. Meunier D, Boyd D, Mulvey MR, Baucheron S, Mammina C, Nastasi A, Chaslus-Dancla E, Cloeckaert A. 2002. Salmonella enterica serotype Typhimurium DT 104 antibiotic resistance genomic island I in serotype paratyphi B. Emerg. Infect. Dis. 8:430-433.
58. Molineux I. 1991. Host-parasite interactions: recent developments in the genetics of abortive phage infections. The New biologist 3:230.
59. O'Flaherty S, Ross RP, Coffey A. 2009. Bacteriophage and their lysins for elimination of infectious bacteria. FEMS Microbiol. Rev. 33:801-819.
60. O'Flynn G, Coffey A, Fitzgerald GF, Ross RP. 2006. The newly isolated lytic bacteriophages st104a and st104b are highly virulent against
Salmonella enterica. J. Appl. Microbiol. 101:251-259.
61. Parma DH, Snyder M, Sobolevski S, Nawroz M, Brody E, Gold L.
1992. The Rex system of bacteriophage lambda: tolerance and altruistic cell death. Genes Development 6:497-510.
62. Payne RJH, Jansen VAA. 2000. Phage therapy: The peculiar kinetics of self-replicating pharmaceuticals. Clin. Pharmacol. Ther. 68:225-230.
63. Pedruzzi I, Rosenbusch JP, Locher KP. 1998. Inactivation in vitro of the Escherichia coli outer membrane protein FhuA by a phage T5‐encoded lipoprotein. FEMS Microbiol. Lett. 168:119-125.
64. Pickard D, Toribio AL, Petty NK, de Tonder A, Yu L, Goulding D, Barrell B, Rance R, Harris D, Wetter M, Wain J, Choudhary J,
Thomson N, Dougan G. 2010. A conserved acetyl esterase domain targets diverse bacteriophage to the Vi capsular receptor of Salmonella enterica serovar Typhi. J. Bacteriol. 192:5746-5754.
65. Pingoud A, Fuxreiter M, Pingoud V, Wende W. 2005. Type II restriction endonucleases: structure and mechanism. Cellular Molecular Life
Sciences 62:685-707.
66. Ricci V, Piddock LJV. 2010. Exploiting the role of TolC in pathogenicity:
identification of a bacteriophage for eradication of Salmonella serovars from poultry. Appl. Environ. Microbiol. 76:1704-1706.
67. Riede I, Eschbach M-L. 1986. Evidence that TraT interacts with OmpA of Escherichia coli. FEBS lett. 205:241-245.
68. Salgado CJ, Zayas M, Villafane R. 2004. Homology between two different Salmonella phages: Salmonella enterica serovar Typhimurium phage P22 and Salmonella enterica serovar Anatum var. 15 + Phage ε34.
Virus Genes 29:87-98.
69. Samuel ADT, Pitta TP, Ryu WS, Danese PN, Leung ECW, Berg HC.
1999. Flagellar determinants of bacterial sensitivity to x-phage. Proc. Nat.
Acad. Sci. USA 96:9863-9866.
70. Savini V, Favaro M, Fontana C, Catavitello C, Balbinot A, Talia M, Febbo F, D'Antonio D. 2009. Bacillus cereus heteroresistance to carbapenems in a cancer patient. J. Hosp. Infect. 71:288-290.
71. Scholl D, Adhya S, Merril C. 2005. Escherichia coli K1's capsule is a barrier to bacteriophage T7. Appl. Environ. Microbiol. 71:4872-4874.
72. Shin H, Bandara N, Shin E, Ryu S, Kim K-p. 2011. Prevalence of Bacillus cereus bacteriophages in fermented foods and characterization of phage JBP901. Res. Microbiol. 162:791-797.
73. Sorek R, Kunin V, Hugenholtz P. 2008. CRISPR—a widespread system that provides acquired resistance against phages in bacteria and archaea.
Nature Rev. Microbiol. 6:181-186.
74. Sturino JM, Klaenhammer TR. 2006. Engineered bacteriophage-defence systems in bioprocessing. Nature Rev. Microbiol. 4:395-404.
75. Twort FW. 1915. An investigation on the nature of ultra-microscopic viruses. The Lancet 186:1241-1243.
76. Vilas-Boas GT, Peruca AP, Arantes OM. 2007. Biology and taxonomy of Bacillus cereus, Bacillus anthracis, and Bacillus thuringiensis.
Canadian J. Microbiol. 53:673-687.
77. Wommack KE, Colwell RR. 2000. Virioplankton: viruses in aquatic
ecosystems. Microbiol. Mol. Biol. Rev. 64:69-114.
78. Ye J, Kostrzynska M, Dunfield K, Warriner K. 2010. Control of Salmonella on sprouting mung bean and alfalfa seeds by using a biocontrol preparation based on antagonistic bacteria and lytic bacteriophages. J. Food Protect. 73:9-17.
79. Zhang J, Kraft BL, Pan Y, Wall SK, Saez AC, Ebner PD. 2010.
Development of an anti-Salmonella phage cocktail with increased host range. Foodborne Pathogens and Disease 7:1415-1419.